naphthacenes - CISMeF

Preferred Label : naphthacenes;

MeSH definition : Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES.;

MeSH synonym : benz(b)anthracenes; tetracenes;

Codes EINECS : 202-138-9;

Is substance : O;

Détails

Origin ID

D009279;

UMLS CUI

C0027374;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- benz[a]anthracene [Substance BNPC]
Currated CISMeF NLP mapping
- Naphthacene (substance) [SNOMED CT concept]
Record concept(s)
- naphthacenes [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,3,8,11-tetrahydroxy-naphthacene-5,12-dione(10-deoxysaintopin) [MeSH Supplementary Concept]
- 2,4,8,11-tetrahydroxy-15-methyl-11,12,14,15-tetrahydro-17-oxahexaphene-1,3,10-trione [MeSH Supplementary Concept]
- 2-methoxyrhamnosyltetracenomycin C [MeSH Supplementary Concept]
- 4'''-aclacinomycinamide [MeSH Supplementary Concept]
- 4'''-deoxy-4'''-aminoaclacinomycin [MeSH Supplementary Concept]
- 4,8-di-O-methyl-saintopin1,10,11-trihydroxy-3,8-dimethoxy-naphthacene-5,12-dione [MeSH Supplementary Concept]
- 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a pentahydroxy naphthacene carboxamide [MeSH Supplementary Concept]
- 4-O-(glucopyranosyl)-epsilon-rhodomycinone [MeSH Supplementary Concept]
- 4-demethoxy-1,4-dimethyldaunomycinone [MeSH Supplementary Concept]
- 4-hydroxyzinowol [MeSH Supplementary Concept]
- 5,12-naphthacenequinone [MeSH Supplementary Concept]
- 5,6-11,12-bis(dithio)tetracene [MeSH Supplementary Concept]
- 5,6-dihydrobenzo(a)naphthacenequinone [MeSH Supplementary Concept]
- 5838 DNI [MeSH Supplementary Concept]
- 6,13-pentacenequinone [MeSH Supplementary Concept]
- 6,6'-dibromo-(1,1'-binaphthalene)-2,2'-diol [MeSH Supplementary Concept]
- 6-hydroxytetracenomycin C [MeSH Supplementary Concept]
- 7-deoxy-13-dihydrodaunorubicinone [MeSH Supplementary Concept]
- 7-deoxyadriamycin aglycone [MeSH Supplementary Concept]
- 7-deoxyadriamycinol aglycone [MeSH Supplementary Concept]
- 7-hydroxyadriamycin aglycone [MeSH Supplementary Concept]
- BMS 192548 [MeSH Supplementary Concept]
- SF 2446A1 [MeSH Supplementary Concept]
- TMC 66 [MeSH Supplementary Concept]
- UCE 1022 [MeSH Supplementary Concept]
- XR651 [MeSH Supplementary Concept]
- adriamycin aglycone [MeSH Supplementary Concept]
- aklaviketone [MeSH Supplementary Concept]
- aklavinone [MeSH Supplementary Concept]
- alpha(2)-rhodomycinone [MeSH Supplementary Concept]
- aranciamycinone [MeSH Supplementary Concept]
- benastatin A [MeSH Supplementary Concept]
- benastatin B [MeSH Supplementary Concept]
- benastatin C [MeSH Supplementary Concept]
- benastatin D [MeSH Supplementary Concept]
- bequinostatin A [MeSH Supplementary Concept]
- bequinostatin B [MeSH Supplementary Concept]
- bequinostatin C [MeSH Supplementary Concept]
- bequinostatin D [MeSH Supplementary Concept]
- beta-isorhodomycinone [MeSH Supplementary Concept]
- bisanhydro-13-dihydrodaunomycinone [MeSH Supplementary Concept]
- bisbenzotetracyclo(6.2.2.2(3,6).0(2,7))tetradeca-4,9,11,13-tetraene [MeSH Supplementary Concept]
- cudraflavone A [MeSH Supplementary Concept]
- daunomycinone [MeSH Supplementary Concept]
- desalaninebenanomicin A [MeSH Supplementary Concept]
- dihydro-5,6,7,12,13,14-hexaazapentacene [MeSH Supplementary Concept]
- doxorubicinolone [MeSH Supplementary Concept]
- galtamycinone [MeSH Supplementary Concept]
- hibarimicin B [MeSH Supplementary Concept]
- hibarimicinone [MeSH Supplementary Concept]
- naphthacemycin A9 [MeSH Supplementary Concept]
- naphthacene [MeSH Supplementary Concept]
- pHLIP-SS-DOX [MeSH Supplementary Concept]
- pentacene [MeSH Supplementary Concept]
- quanolirone I [MeSH Supplementary Concept]
- quanolirone II [MeSH Supplementary Concept]
- rhamnosyltetracenomycin C [MeSH Supplementary Concept]
- rubrene [MeSH Supplementary Concept]
- tetrabenzo(de,hi,mn,qr)naphthacene [MeSH Supplementary Concept]
- tetraceno(2,3-b)thiophene [MeSH Supplementary Concept]
- tetracenomycin B3 [MeSH Supplementary Concept]
- tetracenomycin C [MeSH Supplementary Concept]
- tetracenomycin D3 [MeSH Supplementary Concept]
- tetracenomycin F1 [MeSH Supplementary Concept]
- tetracenomycin X [MeSH Supplementary Concept]
- teuvincenone K [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients